Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5

Yue Huang1, Jingli Yan2, Qi Li1

  • 1CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.

Nucleic Acids Research
|December 3, 2014
PubMed

Insights

Meclofenamic acid selectively inhibits the FTO enzyme, a key player in mRNA demethylation. This discovery offers new tools for studying FTO and developing targeted medical treatments.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Epigenetics

Background:

  • N(6)-methyladenosine (m(6)A) is a prevalent mRNA modification.
  • FTO and ALKBH5 are human demethylases that remove m(6)A.
  • Selective inhibition of FTO over ALKBH5 is a significant challenge.

Purpose of the Study:

  • To identify a selective inhibitor of the FTO enzyme.
  • To elucidate the mechanism of FTO inhibition.
  • To explore the therapeutic potential of FTO inhibitors.

Main Methods:

  • Screening for FTO inhibitors.
  • Mechanistic studies of inhibitor binding.
  • Structural analysis of FTO/inhibitor complex.
  • Cell-based assays to assess m(6)A levels.

Main Results:

  • Meclofenamic acid (MA) identified as a potent and selective FTO inhibitor.
  • MA competes with m(6)A-containing nucleic acids for FTO binding.
  • Structural insights into FTO inhibition and selectivity.
  • MA treatment increases m(6)A levels in mRNA in HeLa cells.

Conclusions:

  • Meclofenamic acid is a valuable chemical probe for FTO.
  • Understanding FTO inhibition principles aids in designing future therapeutics.
  • Selective FTO inhibition has potential applications in medicine.

Related Concept Videos

Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
920
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
934
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.4K
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
83